Screener
ResMed RMD Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
The source filing: ResMed’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 6:19 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000943819-26-000025
FAQ
- What is ResMed's net debt / EBITDA?
- ResMed (RMD) reported net debt / EBITDA of -0.3× in Q1 2026.
- How has ResMed's net debt / EBITDA changed year-over-year?
- ResMed's net debt / EBITDA decreased by 468.5% year-over-year, from -0× to -0.3×.
- What is the long-term trend for ResMed's net debt / EBITDA?
- Over 4 years (2021 to 2025), ResMed's net debt / EBITDA has grown at a -21.3% compound annual growth rate (CAGR), from 0.5× to -0.2×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about ResMed's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude